当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:45.13亿  总市值:46.77亿
流通股本:21.91亿   总股本:22.71亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润1.29亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益171023.08万元,未分配利润-91350.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产315245.01万元,负债144221.93万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入2,626,039,306.712,052,008,504.71,432,663,200.48681,168,970.96
营业总成本2,489,293,946.971,937,036,701.961,339,988,733636,373,987.48
营业利润175,046,611.96260,409,694.6751,371,381.1632,216,202.85
利润总额176,778,148.92260,197,852.8351,380,819.8332,013,464.93
净利润128,700,640.73231,061,077.3232,283,048.3221,870,444.7
其他综合收益855,100.91,361,428.991,640,231.73-714,035.49
综合收益总额129,555,741.63232,422,506.3133,923,280.0521,156,409.21
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计1,154,449,660.951,529,637,539.341,460,639,960.041,738,338,700.12
非流动资产合计1,998,000,444.242,029,693,9392,156,974,626.432,210,063,020.98
资产总计3,152,450,105.193,559,331,478.343,617,614,586.473,948,401,721.1
流动负债合计1,412,228,273.021,669,734,742.291,858,913,339.342,201,855,301.72
非流动负债合计29,991,012.5431,499,151.7532,659,125.4233,298,792.77
负债合计1,442,219,285.561,701,233,894.041,891,572,464.762,235,154,094.49
归属于母公司股东权益合计1,661,773,347.481,789,805,037.641,661,153,081.441,650,582,142.66
股东权益合计1,710,230,819.631,858,097,584.31,726,042,121.711,713,247,626.61
负债和股东权益合计3,152,450,105.193,559,331,478.343,617,614,586.473,948,401,721.1
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计3,081,896,412.42,396,362,568.51,603,357,651.34770,068,919.43
经营活动现金流出小计2,807,721,127.832,089,222,023.951,400,886,902.41686,369,552.28
经营活动产生的现金流量净额274,175,284.57307,140,544.55202,470,748.9383,699,367.15
投资活动现金流入小计529,194,239.47494,449,262.81345,930,246.9857,198,472.28
投资活动现金流出小计434,814,506.23386,688,634.3303,647,516.932,051,240.2
投资活动产生的现金流量净额94,379,733.24107,760,628.5142,282,730.0825,147,232.08
筹资活动现金流入小计1,095,160,0001,095,160,0001,095,160,000695,195,000
筹资活动现金流出小计1,984,319,557.161,805,985,934.611,597,096,061.35796,453,939.96
筹资活动产生的现金流量净额-889,159,557.16-710,825,934.61-501,936,061.35-101,258,939.96
汇率变动对现金及现金等价物的影响987,343.681,842,931.272,189,526.22-771,945.18
现金及现金等价物净增加额-519,617,195.67-294,081,830.28-254,993,056.126,815,714.09
期末现金及现金等价物余额711,004,118.52936,539,483.91975,628,258.071,237,435,456.33
TOP↑